Progressive weakness of muscles is characteristic for this disease, and occurs also in MPS I. The CAPN2 gene encodes calpain 2, a calcium-dependent protease which function has been proposed to be associated with synaptic plasticity, and its dysregulation may lead to neurodegeneration [37]. Here, CAPN2 is linked to Scheie syndrome.